{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:30:07Z","timestamp":1785306607142,"version":"3.55.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Ministry of Health, Welfare and Sport"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Young children and older adults are susceptible for invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae. Pneumococcal protein-specific antibodies play a protective role against IPD; however, not much is known about the pace of acquisition, maturation, and maintenance of these antibodies throughout life.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Immunoglobulin G (IgG) and IgA levels, avidity, and\/or specificity to the pneumococcal proteome in serum and saliva from healthy young children, adults, and older adults, with known carriage status, were measured by enzyme-linked immunosorbent assay (ELISA) and 2-dimensional western blotting against \u0394cpsTIGR4.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Eleven-month-old children, the youngest age group tested, had the lowest pneumococcal proteome-specific IgG and IgA levels and avidity in serum and saliva, followed by 24-month-old children and were further elevated in adult groups. Among adult groups, the parents had the highest serum and saliva IgG and IgA antibody levels. In children, antibody levels and avidity correlated with daycare attendance and presence of siblings, posing as proxy for exposure and immunization. Immunodominance patterns slightly varied throughout life.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Humoral immunity against the pneumococcal proteome is acquired through multiple episodes of pneumococcal exposure. Low-level and low-avidity antiproteome antibody profiles in young children may contribute to their IPD susceptibility, while in overall antiproteome antibody-proficient older adults other factors likely play a role.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiae255","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T22:09:51Z","timestamp":1718748591000},"page":"1466-1475","source":"Crossref","is-referenced-by-count":5,"title":["Quantity and Quality of Naturally Acquired Antibody Immunity to the Pneumococcal Proteome Throughout Life"],"prefix":"10.1093","volume":"230","author":[{"given":"Marloes","family":"Vissers","sequence":"first","affiliation":[{"name":"Centre for Infectious Disease Control, National Institute for Public Health and the Environment , Bilthoven ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0509-7713","authenticated-orcid":false,"given":"Martijn D B","family":"van de Garde","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Control, National Institute for Public Health and the Environment , Bilthoven ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha W J","family":"He","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Control, National Institute for Public Health and the Environment , Bilthoven ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milou","family":"Brandsen","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Control, National Institute for Public Health and the Environment , Bilthoven ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanne","family":"Hendriksen","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Control, National Institute for Public Health and the Environment , Bilthoven ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mioara Alina","family":"Nicolaie","sequence":"additional","affiliation":[{"name":"Expertise Centre for Methodology and Information Services, National Institute for Public Health and the Environment , Bilthoven ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"van der Maas","sequence":"additional","affiliation":[{"name":"Product Characterization and Formulation, Institute for Translational Vaccinology , Bilthoven ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo D","family":"Meiring","sequence":"additional","affiliation":[{"name":"Product Characterization and Formulation, Institute for Translational Vaccinology , Bilthoven ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile A C M","family":"van Els","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Control, National Institute for Public Health and the Environment , Bilthoven ,","place":["The Netherlands"]},{"name":"Infectious Diseases and Immunology, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josine","family":"van Beek","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Control, National Institute for Public Health and the Environment , Bilthoven ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7170-7826","authenticated-orcid":false,"given":"Nynke Y","family":"Rots","sequence":"additional","affiliation":[{"name":"Centre for Infectious Disease Control, National Institute for Public Health and the Environment , Bilthoven ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"key":"2024121523504986800_jiae255-B1","doi-asserted-by":"crossref","first-page":"e1006137","DOI":"10.1371\/journal.ppat.1006137","article-title":"Naturally acquired human immunity to pneumococcus is dependent on antibody to protein antigens","volume":"13","author":"Wilson","year":"2017","journal-title":"PLoS Pathog"},{"key":"2024121523504986800_jiae255-B2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/mi.2016.71","article-title":"Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage","volume":"10","author":"Mitsi","year":"2017","journal-title":"Mucosal Immunol"},{"key":"2024121523504986800_jiae255-B3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/mi.2014.55","article-title":"Antibody blocks acquisition of bacterial colonization through agglutination","volume":"8","author":"Roche","year":"2015","journal-title":"Mucosal Immunol"},{"key":"2024121523504986800_jiae255-B4","doi-asserted-by":"crossref","first-page":"e1006665","DOI":"10.1371\/journal.ppat.1006665","article-title":"The immunological mechanisms that control pneumococcal carriage","volume":"13","author":"Jochems","year":"2017","journal-title":"PLoS Pathog"},{"key":"2024121523504986800_jiae255-B5","doi-asserted-by":"crossref","first-page":"e0194823","DOI":"10.1371\/journal.pone.0194823","article-title":"Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands","volume":"13","author":"Vissers","year":"2018","journal-title":"PLoS One"},{"key":"2024121523504986800_jiae255-B6","doi-asserted-by":"crossref","first-page":"e0226353","DOI":"10.1371\/journal.pone.0226353","article-title":"The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007\u20132017","volume":"14","author":"Wijayasri","year":"2019","journal-title":"PLoS One"},{"key":"2024121523504986800_jiae255-B7","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/IAI.01379-10","article-title":"Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study","volume":"79","author":"Lebon","year":"2011","journal-title":"Infect Immun"},{"key":"2024121523504986800_jiae255-B8","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1128\/IAI.71.10.5724-5732.2003","article-title":"Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization","volume":"71","author":"McCool","year":"2003","journal-title":"Infect Immun"},{"key":"2024121523504986800_jiae255-B9","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1086\/315822","article-title":"Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media","volume":"182","author":"Rapola","year":"2000","journal-title":"J Infect Dis"},{"key":"2024121523504986800_jiae255-B10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1164\/rccm.202004-1483OC","article-title":"Experimental human pneumococcal colonization in older adults is feasible and safe, not immunogenic","volume":"203","author":"Adler","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024121523504986800_jiae255-B11","doi-asserted-by":"crossref","first-page":"832254","DOI":"10.3389\/fcimb.2022.832254","article-title":"Pneumococcal surface proteins as virulence factors, immunogens, and conserved vaccine targets","volume":"12","author":"Aceil","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"2024121523504986800_jiae255-B12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.maturitas.2015.05.004","article-title":"Immunosenescence: implications for response to infection and vaccination in older people","volume":"82","author":"Pera","year":"2015","journal-title":"Maturitas"},{"key":"2024121523504986800_jiae255-B13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jim.2018.08.005","article-title":"Aging and the immune system: an overview","volume":"463","author":"Sadighi Akha","year":"2018","journal-title":"J Immunol Methods"},{"key":"2024121523504986800_jiae255-B14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000504490","article-title":"Vaccines to protect older adults against pneumococcal disease","volume":"43","author":"van de Garde","year":"2020","journal-title":"Interdiscip Top Gerontol Geriatr"},{"key":"2024121523504986800_jiae255-B15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41590-021-00927-z","article-title":"Hallmarks of T cell aging","volume":"22","author":"Mittelbrunn","year":"2021","journal-title":"Nat Immunol"},{"key":"2024121523504986800_jiae255-B16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nri2508","article-title":"B-cell responses to vaccination at the extremes of age","volume":"9","author":"Siegrist","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2024121523504986800_jiae255-B17","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/CVI.00110-08","article-title":"Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins","volume":"15","author":"Simell","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"2024121523504986800_jiae255-B18","doi-asserted-by":"crossref","first-page":"e0247056","DOI":"10.1371\/journal.pone.0247056","article-title":"Serum levels of anti-PspA and anti-PspC IgG decrease with age and do not correlate with susceptibility to experimental human pneumococcal colonization","volume":"16","author":"Araujo","year":"2021","journal-title":"PLoS One"},{"key":"2024121523504986800_jiae255-B19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2024121523504986800_jiae255-B20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2024121523504986800_jiae255-B21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.vaccine.2015.11.060","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in The Netherlands","volume":"34","author":"Bosch","year":"2016","journal-title":"Vaccine"},{"key":"2024121523504986800_jiae255-B22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/infdis\/jix268","article-title":"Influenza-like illness incidence is not reduced by influenza vaccination in a cohort of older adults, despite effectively reducing laboratory-confirmed influenza virus infections","volume":"216","author":"van Beek","year":"2017","journal-title":"J Infect Dis"},{"key":"2024121523504986800_jiae255-B23","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"2024121523504986800_jiae255-B24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/01.inf.0000049347.42983.77","article-title":"Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae","volume":"22","author":"O'Brien","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"2024121523504986800_jiae255-B25","doi-asserted-by":"crossref","first-page":"e39730","DOI":"10.1371\/journal.pone.0039730","article-title":"Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis","volume":"7","author":"Spijkerman","year":"2012","journal-title":"PLoS One"},{"key":"2024121523504986800_jiae255-B26","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1128\/IAI.01823-06","article-title":"Analysis of the in vitro transcriptional response of human pharyngeal epithelial cells to adherent Streptococcus pneumoniae: evidence for a distinct response to encapsulated strains","volume":"75","author":"Bootsma","year":"2007","journal-title":"Infect Immun"},{"key":"2024121523504986800_jiae255-B27","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1021\/acs.jproteome.5b00258","article-title":"Immunoproteomic profiling of Bordetella pertussis outer membrane vesicle vaccine reveals broad and balanced humoral immunogenicity","volume":"14","author":"Raeven","year":"2015","journal-title":"J Proteome Res"},{"key":"2024121523504986800_jiae255-B28","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3389\/fimmu.2019.01364","article-title":"Antibody specificity following a recent Bordetella pertussis infection in adolescence is correlated with the pertussis vaccine received in childhood","volume":"10","author":"Raeven","year":"2019","journal-title":"Front Immunol"},{"key":"2024121523504986800_jiae255-B29","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1002\/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6","article-title":"A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption\/ionization and electrospray ionization-mass spectrometry","volume":"21","author":"Yan","year":"2000","journal-title":"Electrophoresis"},{"key":"2024121523504986800_jiae255-B30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F","article-title":"Nanoscale LC\u2013MS(n): technical design and applications to peptide and protein analysis","volume":"25","author":"Meiring","year":"2002","journal-title":"J Sep Sci"},{"key":"2024121523504986800_jiae255-B31","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jama.1995.03520350041026","article-title":"Risk factors for primary invasive pneumococcal disease among children in Finland","volume":"273","author":"Takala","year":"1995","journal-title":"JAMA"},{"key":"2024121523504986800_jiae255-B32","doi-asserted-by":"crossref","first-page":"e0000327","DOI":"10.1371\/journal.pgph.0000327","article-title":"Factors associated with pneumococcal nasopharyngeal carriage: a systematic review","volume":"2","author":"Neal","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"2024121523504986800_jiae255-B33","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/CVI.00341-16","article-title":"Natural development of antibodies against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis protein antigens during the first 13 years of life","volume":"23","author":"Borges","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"2024121523504986800_jiae255-B34","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1128\/IAI.72.6.3331-3335.2004","article-title":"Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal Kenya","volume":"72","author":"Laine","year":"2004","journal-title":"Infect Immun"},{"key":"2024121523504986800_jiae255-B35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/eji.200535101","article-title":"Serum and mucosal antibody responses to pneumococcal protein antigens in children: relationships with carriage status","volume":"36","author":"Zhang","year":"2006","journal-title":"Eur J Immunol"},{"key":"2024121523504986800_jiae255-B36","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1128\/iai.65.10.3997-4004.1997","article-title":"Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans","volume":"65","author":"Quan","year":"1997","journal-title":"Infect Immun"},{"key":"2024121523504986800_jiae255-B37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2567.2004.01958.x","article-title":"IgA function\u2014variations on a theme","volume":"113","author":"Woof","year":"2004","journal-title":"Immunol"},{"key":"2024121523504986800_jiae255-B38","doi-asserted-by":"crossref","first-page":"595297","DOI":"10.3389\/fimmu.2020.595297","article-title":"Understanding early-life adaptive immunity to guide interventions for pediatric health","volume":"11","author":"Semmes","year":"2020","journal-title":"Front Immunol"},{"key":"2024121523504986800_jiae255-B39","doi-asserted-by":"crossref","first-page":"1031924","DOI":"10.3389\/fimmu.2022.1031924","article-title":"The adaptive immune system in early life: the shift makes it count","volume":"13","author":"Pieren","year":"2022","journal-title":"Front Immunol"},{"key":"2024121523504986800_jiae255-B40","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1128\/CVI.00147-14","article-title":"Avidity of antibodies against infecting pneumococcal serotypes increases with age and severity of disease","volume":"21","author":"Cremers","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"2024121523504986800_jiae255-B41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/515644","article-title":"Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults","volume":"178","author":"Rubins","year":"1998","journal-title":"J Infect Dis"},{"key":"2024121523504986800_jiae255-B42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/520200","article-title":"Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity","volume":"29","author":"Romero-Steiner","year":"1999","journal-title":"Clin Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae255\/58271346\/jiae255.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/6\/1466\/61141157\/jiae255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/6\/1466\/61141157\/jiae255.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T23:51:10Z","timestamp":1734306670000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/230\/6\/1466\/7695715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,18]]},"published-print":{"date-parts":[[2024,12,16]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae255","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12,15]]},"published":{"date-parts":[[2024,6,18]]}}}